When is vancomycin contraindicated in the treatment of infective endocarditis (IE)?

Updated: Jan 03, 2019
  • Author: John L Brusch, MD, FACP; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

Vancomycin therapy is associated with a significant failure rate (up to 35%) in the treatment of MSSA and MRSA bloodstream infection (BSI)/IE. It appears that vancomycin should not be used to treat infections with staphylococci with an MIC of greater than 1.5-2 mcg/mL. In these cases, alternative agents such as linezolid or daptomycin should be used.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!